These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9596067)

  • 1. The Home Infusion Therapy/Relative Benefit Index: summary of an analysis using insurance claims data.
    Birnbaum HG; Tang M
    Med Care; 1998 May; 36(5):757-65. PubMed ID: 9596067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data.
    Margolis J; Barron JJ; Grochulski WD
    J Manag Care Pharm; 2005; 11(9):727-34. PubMed ID: 16300416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
    Yokoyama K; Yang W; Preblick R; Frech-Tamas F
    J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actuarial analysis of private payer administrative claims data for women with endometriosis.
    Mirkin D; Murphy-Barron C; Iwasaki K
    J Manag Care Pharm; 2007 Apr; 13(3):262-72. PubMed ID: 17407392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pursuing cost-effectiveness in mental health service delivery for youth with complex needs.
    Grimes KE; Schulz MF; Cohen SA; Mullin BO; Lehar SE; Tien S
    J Ment Health Policy Econ; 2011 Jun; 14(2):73-83. PubMed ID: 21881163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact of high-technology home care.
    Arno PS; Bonuck KA; Padgug R
    Hastings Cent Rep; 1994; 24(5):S15-9. PubMed ID: 8002295
    [No Abstract]   [Full Text] [Related]  

  • 7. A cost containment program targeting home infusion drug therapy.
    Richards JW; Taylor WJ
    Physician Exec; 1994 Nov; 20(11):38-41. PubMed ID: 10140895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.
    Prescott JD; Factor S; Pill M; Levi GW
    J Manag Care Pharm; 2007; 13(1):44-52. PubMed ID: 17269836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A managed care model for home infusion therapy.
    Cerra FB; Kaplan EL; Schwarzenberg SJ; Soltis R; Twiggs L
    Am J Med Qual; 1995; 10(2):93-9. PubMed ID: 7787505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home infusion: Safe, clinically effective, patient preferred, and cost saving.
    Polinski JM; Kowal MK; Gagnon M; Brennan TA; Shrank WH
    Healthc (Amst); 2017 Mar; 5(1-2):68-80. PubMed ID: 28668202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost perspectives for outpatient intravenous antimicrobial therapy.
    Tice AD; Hoaglund PA; Nolet B; McKinnon PS; Mozaffari E
    Pharmacotherapy; 2002 Feb; 22(2 Pt 2):63S-70S. PubMed ID: 11837549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophilia home treatment. Economic analysis and implications for health policy.
    Ross-Degnan D; Soumerai SB; Avorn J; Bohn RL; Bright R; Aledort LM
    Int J Technol Assess Health Care; 1995; 11(2):327-44. PubMed ID: 7790175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP
    J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting to outpatient care? Mental health care use and cost under private insurance.
    Leslie DL; Rosenheck R
    Am J Psychiatry; 1999 Aug; 156(8):1250-7. PubMed ID: 10450268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe intravenous antibiotic therapy at home: experience of a UK based programme.
    Kayley J; Berendt AR; Snelling MJ; Moore H; Hamilton HC; Peto TE; Crook DW; Conlon CP
    J Antimicrob Chemother; 1996 May; 37(5):1023-9. PubMed ID: 8737154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
    Davis KL; Candrilli SD; Edin HM
    Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis.
    Jackson R; Shiozawa A; Buysman EK; Altan A; Korrer S; Choi H
    BMJ Open; 2015 Jun; 5(6):e007214. PubMed ID: 26109113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs associated with attempted suicide among individuals with bipolar disorder.
    Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
    J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of provider self-adjudication using the prudent layperson standard compared with the managed care organization's emergency department claim review process.
    Shesser R; Holtermann K; Smith J; Braun J
    Ann Emerg Med; 2000 Sep; 36(3):212-8. PubMed ID: 10969222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of insurance claims data to assess outpatient antimicrobial therapy for gram-positive infections.
    Carmeli Y; Mozaffari E
    Pharmacotherapy; 2002 Feb; 22(2 Pt 2):55S-62S. PubMed ID: 11837548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.